Susquehanna International Group, LLP Cabaletta Bio, Inc. Transaction History

Susquehanna International Group, LLP

$568 Billion
Q1 2025

A detailed history of Susquehanna International Group, LLP transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 57,780 shares of CABA stock, worth $103,426. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,780

Previous 431,935 86.62%

Holding current value

$103,426

Previous $950,000 91.58%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$1.39 - $2.74 $520,075 - $1.03 Million	-374,155 Reduced 86.62%	57,780 $80,000
Q4 2024 Feb 14, 2025	BUY	$1.87 - $4.91 $764,050 - $2.01 Million	408,583 Added 1749.67%	431,935 $950,000
Q3 2024 Nov 14, 2024	SELL	$3.94 - $8.24 $171,866 - $359,437	-43,621 Reduced 65.13%	23,352 $110,000
Q2 2024 Aug 15, 2024	BUY	$7.22 - $18.82 $20,750 - $54,088	2,874 Added 4.48%	66,973 $500,000
Q1 2024 May 07, 2024	BUY	$16.79 - $25.38 $705,935 - $1.07 Million	42,045 Added 190.65%	64,099 $1.09 Million
Q4 2023 Feb 14, 2024	BUY	$12.21 - $23.36 $269,279 - $515,181	22,054 New	22,054 $500,000
Q1 2023 May 16, 2023	BUY	$7.08 - $12.62 $604,355 - $1.08 Million	85,361 Added 47.42%	265,355 $2.19 Million
Q4 2022 Feb 14, 2023	SELL	$0.64 - $9.3 $54,640 - $793,987	-85,375 Reduced 32.17%	179,994 $1.66 Million
Q3 2022 Nov 14, 2022	BUY	$0.63 - $2.05 $159,535 - $519,123	253,231 Added 2086.27%	265,369 $173,000
Q2 2022 Aug 15, 2022	SELL	$0.99 - $2.11 $15,452 - $32,934	-15,609 Reduced 56.25%	12,138 $13,000
Q1 2022 May 16, 2022	SELL	$1.68 - $3.92 $210,940 - $492,195	-125,560 Reduced 81.9%	27,747 $56,000
Q4 2021 Feb 14, 2022	BUY	$3.36 - $14.64 $320,463 - $1.4 Million	95,376 Added 164.64%	153,307 $581,000
Q3 2021 Nov 15, 2021	BUY	$7.0 - $12.5 $262,787 - $469,262	37,541 Added 184.11%	57,931 $704,000
Q2 2021 Aug 11, 2021	BUY	$7.2 - $11.73 $12,160 - $19,811	1,689 Added 9.03%	20,390 $175,000
Q1 2021 May 17, 2021	BUY	$10.39 - $14.53 $194,303 - $271,725	18,701 New	18,701 $208,000
Q1 2020 May 15, 2020	SELL	$6.0 - $18.67 $74,748 - $232,590	-12,458 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$7.88 - $17.71 $98,169 - $220,631	12,458 New	12,458 $174,000

Others Institutions Holding CABA

# of Institutions

Shares Held

37.8M

Call Options Held

154K

Put Options Held

192K

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $51.9M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Cabaletta Bio, Inc. Transaction History